4-{4-[5-Bromo-4-(4-cyano-2,6-dimethyl-phenoxy)-pyrimidin-2-ylamino]-piperidin-1-ylmethyl}-3-chloro-benzoic acid | 1033951-14-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-{4-[5-Bromo-4-(4-cyano-2,6-dimethyl-phenoxy)-pyrimidin-2-ylamino]-piperidin-1-ylmethyl}-3-chloro-benzoic acid
• 英文别名: 4-[(4-{[5-Bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl]amino}piperidin-1-yl)methyl]-3-chlorobenzoic acid；4-[[4-[[5-bromo-4-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl]amino]piperidin-1-yl]methyl]-3-chlorobenzoic acid
• CAS: 1033951-14-2
• 化学式: C₂₆H₂₅BrClN₅O₃
• 分子量: 570.873
• InChiKey: ACDHMYCDBLZDSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  36
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  111
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  4-[(5-bromo-2-chloropyrimidin-4-yl)oxy]-3,5-dimethylbenzonitrile 、 在 N,N-二异丙基乙胺 作用下， 以 N-甲基吡咯烷酮 为溶剂， 生成 4-{4-[5-Bromo-4-(4-cyano-2,6-dimethyl-phenoxy)-pyrimidin-2-ylamino]-piperidin-1-ylmethyl}-3-chloro-benzoic acid
  参考文献：
  名称：

  Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Benzyl derivatives with broad potency against resistant mutant viruses

  摘要：

  An analysis of the binding motifs of known HIV-1 non-nucleoside reverse transcriptase inhibitors has led to discovery of novel piperidine-linked aminopyrimidine derivatives with broad activity against wildtype as well as drug-resistant mutant viruses. Notably, the series retains potency against the K103 N/Y181C and Y188L mutants, among others. Thus, the N-benzyl compound 5k has a particularly attractive pro. le. Synthesis and SAR are presented and discussed, as well as crystal structures relating to the binding motifs. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.05.040

文献信息

• Non-nucleoside reverse transcriptase inhibitors
  申请人：Kestesz Denis John

  公开号：US20080146595A1

  公开（公告）日：2008-06-19

  The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R 1 , R 2 , R 3 , R 4 , R 5a , R 5b , R 6a , R 6b and X are as herein defined. Also disclosed in the present invention are methods of treating an HIV infection with compounds defined herein and pharmaceutical compositions containing said compounds.

  本发明提供了用于治疗HIV感染、预防HIV感染、治疗AIDS或ARC的化合物。本发明的化合物具有如下式I所示的结构，其中R1、R2、R3、R4、R5a、R5b、R6a、R6b和X的定义如本文所述。本发明还公开了使用上述定义的化合物治疗HIV感染的方法，以及含有这些化合物的药物组合物。
• 2-(PIPERIDIN-4-YL)-4-PHENOXY-OR PHENYLAMINO-PYRIMIDINE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
  申请人：F. Hoffmann-La Roche AG

  公开号：EP2089384B1

  公开（公告）日：2015-08-05
• US7998969B2
  申请人：——

  公开号：US7998969B2

  公开（公告）日：2011-08-16
• [EN] NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS<br/>[FR] INHIBITEURS NON NUCLÉOSIDIQUES DE LA TRANSCRIPTASE INVERSE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2008071587A2

  公开（公告）日：2008-06-19

  [EN] The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula (I) wherein R¹, R², R³, R⁴, R^5a, R^5b, R^6a, R^6b and X are as herein defined. Also disclosed in the present invention are methods of treating an HIV infection with compounds defined herein and pharmaceutical compositions containing said compounds.
  [FR] La présente invention concerne des composés utiles pour traiter une infection par le VIH, ou prévenir une infection par le VIH, ou traiter le SIDA ou le SAS. Les composés de l'invention sont de formule I dans laquelle R¹, R², R³, R⁴, R^5a, R^5b, R^6a, R^6b et X sont tels que définis ici. La présente invention concerne également des procédés de traitement d'une infection par le VIH avec les composés définis ici et des compositions pharmaceutiques contenant lesdits composés.
• Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Benzyl derivatives with broad potency against resistant mutant viruses
  作者：Denis J. Kertesz、Christine Brotherton-Pleiss、Minmin Yang、Zhanguo Wang、Xianfeng Lin、Zongxing Qiu、Donald R. Hirschfeld、Shelley Gleason、Taraneh Mirzadegan、Pete W. Dunten、Seth F. Harris、Armando G. Villaseñor、Julie Qi Hang、Gabrielle M. Heilek、Klaus Klumpp

  DOI：10.1016/j.bmcl.2010.05.040

  日期：2010.7

  An analysis of the binding motifs of known HIV-1 non-nucleoside reverse transcriptase inhibitors has led to discovery of novel piperidine-linked aminopyrimidine derivatives with broad activity against wildtype as well as drug-resistant mutant viruses. Notably, the series retains potency against the K103 N/Y181C and Y188L mutants, among others. Thus, the N-benzyl compound 5k has a particularly attractive pro. le. Synthesis and SAR are presented and discussed, as well as crystal structures relating to the binding motifs. (C) 2010 Elsevier Ltd. All rights reserved.